The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

A systematic approach for the diagnosis and treatment of idiopathic peptic ulcers

  • Chung, Chen-Shuan (Department of Internal Medicine, Far Eastern Memorial Hospital) ;
  • Chiang, Tsung-Hsien (Department of Internal Medicine, National Taiwan University Hospital) ;
  • Lee, Yi-Chia (Department of Internal Medicine, National Taiwan University Hospital)
  • Received : 2015.01.22
  • Accepted : 2015.06.20
  • Published : 2015.09.01
⟨ Previous Next ⟩

Abstract

An idiopathic peptic ulcer is defined as an ulcer with unknown cause or an ulcer that appears to arise spontaneously. The first step in treatment is to exclude common possible causes, including Helicobacter pylori infection, infection with other pathogens, ulcerogenic drugs, and uncommon diseases with upper gastrointestinal manifestations. When all known causes are excluded, a diagnosis of idiopathic peptic ulcer can be made. A patient whose peptic ulcer is idiopathic may have a higher risk for complicated ulcer disease, a poorer response to gastric acid suppressants, and a higher recurrence rate after treatment. Risk factors associated with this disease may include genetic predisposition, older age, chronic mesenteric ischemia, smoking, concomitant diseases, a higher American Society of Anesthesiologists score, and higher stress. Therefore, the diagnosis and management of emerging disease should systematically explore all known causes and treat underlying disease, while including regular endoscopic surveillance to confirm ulcer healing and the use of proton-pump inhibitors on a case-by-case basis.

Keywords

References

  1. Infection with Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994;61:177-240.
  2. Torres J, Lopez L, Lazcano E, Camorlinga M, Flores L, Munoz O. Trends in Helicobacter pylori infection and gastric cancer in Mexico. Cancer Epidemiol Biomarkers Prev 2005;14:1874-1877. https://doi.org/10.1158/1055-9965.EPI-05-0113
  3. Kuipers EJ, Thijs JC, Festen HP. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 1995;9 Suppl 2:59-69.
  4. Lee YC, Chen TH, Chiu HM, et al. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut 2013;62:676-682. https://doi.org/10.1136/gutjnl-2012-302240
  5. IARC Helicobacter pylori Working Group. Helicobacter pylori eradication as a strategy for gastric cancer prevention (IARC Working Group Reports, No. 8) [Internet]. Lyon (FR): International Agency for Research on Cancer, c2015 [cited 2015 Jun 22]. Available from: http://www.iarc.fr/en/publications/pdfs-online/wrk/wrk8/index.php.
  6. Xia B, Xia HH, Ma CW, et al. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong. Aliment Pharmacol Ther 2005;22:243-249. https://doi.org/10.1111/j.1365-2036.2005.02554.x
  7. Uyub AM, Raj SM, Visvanathan R, et al. Helicobacter pylori infection in north-eastern peninsular Malaysia: evidence for an unusually low prevalence. Scand J Gastroenterol 1994;29:209-213. https://doi.org/10.3109/00365529409090465
  8. Sugiyama T, Nishikawa K, Komatsu Y, et al. Attributable risk of H. pylori in peptic ulcer disease: does declining prevalence of infection in general population explain increasing frequency of non-H. pylori ulcers? Dig Dis Sci 2001;46:307-310. https://doi.org/10.1023/A:1005600831851
  9. Singh V, Trikha B, Nain CK, Singh K, Vaiphei K. Epidemiology of Helicobacter pylori and peptic ulcer in India. J Gastroenterol Hepatol 2002;17:659-665. https://doi.org/10.1046/j.1440-1746.2002.02746.x
  10. Asaka M, Kimura T, Kudo M, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992;102:760-766. https://doi.org/10.1016/0016-5085(92)90156-S
  11. Musumba C, Jorgensen A, Sutton L, et al. The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010. Aliment Pharmacol Ther 2012;36:48-56. https://doi.org/10.1111/j.1365-2036.2012.05118.x
  12. Graham DY. Large U.S. clinical trials report a high proportion of H. pylori negative duodenal ulcers at study entry as well as a high recurrence rate after cure of the infection: have we all been wrong? Gastroenterology 1998;114(Suppl 1):A17.
  13. Nensey YM, Schubert TT, Bologna SD, Ma CK. Helicobacter pylori-negative duodenal ulcer. Am J Med 1991;91:15-18. https://doi.org/10.1016/0002-9343(91)90067-8
  14. Sprung DJ, Apter MN. What is the role of Helicobacter pylori in peptic ulcer and gastric cancer outside the big cities? J Clin Gastroenterol 1998;26:60-63. https://doi.org/10.1097/00004836-199801000-00016
  15. Jyotheeswaran S, Shah AN, Jin HO, Potter GD, Ona FV, Chey WY. Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified? Am J Gastroenterol 1998;93:574-578. https://doi.org/10.1111/j.1572-0241.1998.167_b.x
  16. Charpignon C, Lesgourgues B, Pariente A, et al. Peptic ulcer disease: one in five is related to neither Helicobacter pylori nor aspirin/NSAID intake. Aliment Pharmacol Ther 2013;38:946-954. https://doi.org/10.1111/apt.12465
  17. Borody TJ, George LL, Brandl S, et al. Helicobacter pylori-negative duodenal ulcer. Am J Gastroenterol 1991;86:1154-1157.
  18. Higuchi K, Arakawa T, Fujiwara Y, et al. Is Helicobacter pylori-negative duodenal ulcer masked by the high prevalence of H. pylori infection in the general population? Am J Gastroenterol 1999;94:3083-3084.
  19. Tsuji H, Kohli Y, Fukumitsu S, et al. Helicobacter pylori-negative gastric and duodenal ulcers. J Gastroenterol 1999;34:455-460. https://doi.org/10.1007/s005350050296
  20. Arakawa T1, Higuchi K, Fujiwara Y, et al. Helicobacter pylori: criminal or innocent bystander? J Gastroenterol 2000;35 Suppl 12:42-46.
  21. Aoyama N, Shinoda Y, Matsushima Y, et al. Helicobacter pylori-negative peptic ulcer in Japan: which contributes most to peptic ulcer development, Helicobacter pylori, NSAIDS or stress? J Gastroenterol 2000;35 Suppl 12:33-37.
  22. Nishikawa K, Sugiyama T, Kato M, et al. Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population. Eur J Gastroenterol Hepatol 2000;12:635-640. https://doi.org/10.1097/00042737-200012060-00010
  23. Chan HL, Wu JC, Chan FK, et al. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients. Gastrointest Endosc 2001;53:438-442. https://doi.org/10.1067/mge.2001.112840
  24. Kamada T, Haruma K, Kusunoki H, et al. Significance of an exaggerated meal-stimulated gastrin response in pathogenesis of Helicobacter pylori-negative duodenal ulcer. Dig Dis Sci 2003;48:644-651. https://doi.org/10.1023/A:1022808003014
  25. Chu KM, Kwok KF, Law S, Wong KH. Patients with Helicobacter pylori positive and negative duodenal ulcers have distinct clinical characteristics. World J Gastroenterol 2005;11:3518-3522. https://doi.org/10.3748/wjg.v11.i23.3518
  26. Hung LC, Ching JY, Sung JJ, et al. Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study. Gastroenterology 2005;128:1845-1850. https://doi.org/10.1053/j.gastro.2005.03.026
  27. Ong TZ, Hawkey CJ, Ho KY. Nonsteroidal anti-inflammatory drug use is a significant cause of peptic ulcer disease in a tertiary hospital in Singapore: a prospective study. J Clin Gastroenterol 2006;40:795-800. https://doi.org/10.1097/01.mcg.0000225610.41105.7f
  28. Jang HJ, Choi MH, Shin WG, et al. Has peptic ulcer disease changed during the past ten years in Korea? A prospective multi-center study. Dig Dis Sci 2008;53:1527-1531. https://doi.org/10.1007/s10620-007-0028-6
  29. Chen TS, Luo JC, Chang FY. Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan. J Gastroenterol Hepatol 2010;25:919-922. https://doi.org/10.1111/j.1440-1746.2009.06139.x
  30. Wong GL, Au KW, Lo AO, et al. Gastroprotective therapy does not improve outcomes of patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Clin Gastroenterol Hepatol 2012;10:1124-1129. https://doi.org/10.1016/j.cgh.2012.06.012
  31. Kim JJ, Kim N, Park HK, et al. Clinical characteristics of patients diagnosed as peptic ulcer disease in the third referral center in 2007. Korean J Gastroenterol 2012;59:338-346. https://doi.org/10.4166/kjg.2012.59.5.338
  32. Ciociola AA, McSorley DJ, Turner K, Sykes D, Palmer JB. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am J Gastroenterol 1999;94:1834-1840. https://doi.org/10.1111/j.1572-0241.1999.01214.x
  33. Gisbert JP, Blanco M, Mateos JM, et al. H. pylori-negative duodenal ulcer prevalence and causes in 774 patients. Dig Dis Sci 1999;44:2295-2302. https://doi.org/10.1023/A:1026669123593
  34. Meucci G, Di Battista R, Abbiati C, et al. Prevalence and risk factors of Helicobacter pylori-negative peptic ulcer: a multicenter study. J Clin Gastroenterol 2000;31:42-47. https://doi.org/10.1097/00004836-200007000-00010
  35. Arents NL, Thijs JC, van Zwet AA, Kleibeuker JH. Does the declining prevalence of Helicobacter pylori unmask patients with idiopathic peptic ulcer disease? Trends over an 8 year period. Eur J Gastroenterol Hepatol 2004;16:779-783. https://doi.org/10.1097/01.meg.0000108367.19243.73
  36. Sbrozzi-Vanni A, Zullo A, Di Giulio E, et al. Low prevalence of idiopathic peptic ulcer disease: an Italian endoscopic survey. Dig Liver Dis 2010;42:773-776. https://doi.org/10.1016/j.dld.2010.03.019
  37. Vu C, Ng YY. Prevalence of Helicobacter pylori in peptic ulcer disease in a Singapore hospital. Singapore Med J 2000;41:478-481.
  38. Yakoob J, Jafri W, Jafri N, et al. Prevalence of non-Helicobacter pylori duodenal ulcer in Karachi, Pakistan. World J Gastroenterol 2005;11:3562-3565. https://doi.org/10.3748/wjg.v11.i23.3562
  39. Ootani H, Iwakiri R, Shimoda R, et al. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan. J Gastroenterol 2006;41:41-46. https://doi.org/10.1007/s00535-005-1720-y
  40. Goenka MK, Majumder S, Sethy PK, Chakraborty M. Helicobacter pylori negative, non-steroidal anti-inflammatory drug-negative peptic ulcers in India. Indian J Gastroenterol 2011;30:33-37. https://doi.org/10.1007/s12664-011-0085-9
  41. Kang JM, Seo PJ, Kim N, et al. Analysis of direct medical care costs of peptic ulcer disease in a Korean tertiary medical center. Scand J Gastroenterol 2012;47:36-42. https://doi.org/10.3109/00365521.2011.639083
  42. Uyanikoglu A, Danalioglu A, Akyuz F, et al. Etiological factors of duodenal and gastric ulcers. Turk J Gastroenterol 2012;23:99-103. https://doi.org/10.4318/tjg.2012.0435
  43. Yoon H, Kim SG, Jung HC, Song IS. High recurrence rate of idiopathic peptic ulcers in long-term follow-up. Gut Liver 2013;7:175-181. https://doi.org/10.5009/gnl.2013.7.2.175
  44. Chow DK, Sung JJ. Non-NSAID non-H. pylori ulcer disease. Best Pract Res Clin Gastroenterol 2009;23:3-9.
  45. Quan C, Talley NJ. Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs. Am J Gastroenterol 2002;97:2950-2961. https://doi.org/10.1111/j.1572-0241.2002.07068.x
  46. Gisbert JP, Abraira V. Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis. Am J Gastroenterol 2006;101:848-863. https://doi.org/10.1111/j.1572-0241.2006.00528.x
  47. Raj SM, Yap K, Haq JA, Singh S, Hamid A. Further evidence for an exceptionally low prevalence of Helicobacter pylori infection among peptic ulcer patients in north-eastern peninsular Malaysia. Trans R Soc Trop Med Hyg 2001;95:24-27. https://doi.org/10.1016/S0035-9203(01)90319-0
  48. Laine L, Estrada R, Trujillo M, Knigge K, Fennerty MB. Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori. Ann Intern Med 1998;129:547-550. https://doi.org/10.7326/0003-4819-129-7-199810010-00007
  49. Chey WD, Woods M, Scheiman JM, Nostrant TT, DelValle J. Lansoprazole and ranitidine affect the accuracy of the 14C-urea breath test by a pH-dependent mechanism. Am J Gastroenterol 1997;92:446-450.
  50. Lee JM, Breslin NP, Fallon C, O'Morain CA. Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding. Am J Gastroenterol 2000;95:1166-1170. https://doi.org/10.1111/j.1572-0241.2000.02004.x
  51. Lee TH, Lin CC, Chung CS, Lin CK, Liang CC, Tsai KC. Increasing biopsy number and sampling from gastric body improve the sensitivity of rapid urease test in patients with peptic ulcer bleeding. Dig Dis Sci 2015;60:454-457. https://doi.org/10.1007/s10620-014-3351-8
  52. Leung WK, Sung JJ, Siu KL, Chan FK, Ling TK, Cheng AF. False-negative biopsy urease test in bleeding ulcers caused by the buffering effects of blood. Am J Gastroenterol 1998;93:1914-1918. https://doi.org/10.1111/j.1572-0241.1998.00457.x
  53. Bayerdorffer E, Oertel H, Lehn N, et al. Topographic association between active gastritis and Campylobacter pylori colonisation. J Clin Pathol 1989;42:834-839. https://doi.org/10.1136/jcp.42.8.834
  54. Genta RM, Graham DY. Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. Gastrointest Endosc 1994;40:342-345. https://doi.org/10.1016/S0016-5107(94)70067-2
  55. Craanen ME, Dekker W, Blok P, Ferwerda J, Tytgat GN. Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut 1992;33:16-20. https://doi.org/10.1136/gut.33.1.16
  56. Hirschowitz BI, Lanas A. Intractable upper gastrointestinal ulceration due to aspirin in patients who have undergone surgery for peptic ulcer. Gastroenterology 1998;114:883-892. https://doi.org/10.1016/S0016-5085(98)70307-5
  57. Lanas A, Serrano P, Bajador E, Esteva F, Benito R, Sainz R. Evidence of aspirin use in both upper and lower gastrointestinal perforation. Gastroenterology 1997;112:683-689. https://doi.org/10.1053/gast.1997.v112.pm9041228
  58. Blank MA, Ems BL, Gibson GW, et al. Nonclinical model for assessing gastric effects of bisphosphonates. Dig Dis Sci 1997;42:281-288. https://doi.org/10.1023/A:1018849415297
  59. Graham DY, Malaty HM. Alendronate gastric ulcers. Aliment Pharmacol Ther 1999;13:515-519. https://doi.org/10.1046/j.1365-2036.1999.00488.x
  60. Pruitt RE, Truss CD. Endoscopy, gastric ulcer, and gastric cancer: follow-up endoscopy for all gastric ulcers? Dig Dis Sci 1993;38:284-288. https://doi.org/10.1007/BF01307545
  61. Podolsky I, Storms PR, Richardson CT, Peterson WL, Fordtran JS. Gastric adenocarcinoma masquerading endoscopically as benign gastric ulcer: a five-year experience. Dig Dis Sci 1988;33:1057-1063. https://doi.org/10.1007/BF01535778
  62. Saini SD, Eisen G, Mattek N, Schoenfeld P. Utilization of upper endoscopy for surveillance of gastric ulcers in the United States. Am J Gastroenterol 2008;103:1920-1925. https://doi.org/10.1111/j.1572-0241.2008.01945.x
  63. Breslin NP, Sutherland LR. Survey of current practices among members of CAG in the follow-up of patients diagnosed with gastric ulcer. Can J Gastroenterol 1999;13:489-493. https://doi.org/10.1155/1999/738907
  64. Kaltenbach T, Sano Y, Friedland S, Soetikno R; American Gastroenterological Association. American Gastroenterological Association (AGA) Institute technology assessment on image-enhanced endoscopy. Gastroenterology 2008;134:327-340. https://doi.org/10.1053/j.gastro.2007.10.062
  65. Goh KL. Prevalence of and risk factors for Helicobacter pylori infection in a multi-racial dyspeptic Malaysian population undergoing endoscopy. J Gastroenterol Hepatol 1997;12:S29-S35. https://doi.org/10.1111/j.1440-1746.1997.tb00455.x
  66. Niv Y, Boltin D, Halpern M, et al. Membrane-bound mucins and mucin terminal glycans expression in idiopathic or Helicobacter pylori, NSAID associated peptic ulcers. World J Gastroenterol 2014;20:14913-14920. https://doi.org/10.3748/wjg.v20.i40.14913
  67. Niv Y, Boltin D. Secreted and membrane-bound mucins and idiopathic peptic ulcer disease. Digestion 2012;86:258-263. https://doi.org/10.1159/000341423
  68. Azuma T, Konishi J, Ito Y, et al. Genetic differences between duodenal ulcer patients who were positive or negative for Helicobacter pylori. J Clin Gastroenterol 1995;21 Suppl 1:S151-S154.
  69. Xia HH, Wong BC, Wong KW, et al. Clinical and endoscopic characteristics of non-Helicobacter pylori, non-NSAID duodenal ulcers: a long-term prospective study. Aliment Pharmacol Ther 2001;15:1875-1882. https://doi.org/10.1046/j.1365-2036.2001.01115.x
  70. Cryer B, Redfern JS, Goldschmiedt M, Lee E, Feldman M. Effect of aging on gastric and duodenal mucosal prostaglandin concentrations in humans. Gastroenterology 1992;102(4 Pt 1):1118-1123. https://doi.org/10.1016/0016-5085(92)90746-L
  71. Lee YC, Yen AM, Tai JJ, et al. The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut 2009;58:174-181. https://doi.org/10.1136/gut.2008.162305
  72. Ma L, Chow JY, Cho CH. Effects of cigarette smoking on gastric ulcer formation and healing: possible mechanisms of action. J Clin Gastroenterol 1998;27 Suppl 1:S80-S86. https://doi.org/10.1097/00004836-199800001-00013
  73. Luo JC, Leu HB, Hou MC, et al. Cirrhotic patients at increased risk of peptic ulcer bleeding: a nationwide population-based cohort study. Aliment Pharmacol Ther 2012;36:542-550. https://doi.org/10.1111/j.1365-2036.2012.05225.x
  74. Kanno T, Iijima K, Abe Y, et al. Hemorrhagic ulcers after Great East Japan Earthquake and Tsunami: features of post-disaster hemorrhagic ulcers. Digestion 2013;87:40-46. https://doi.org/10.1159/000343937
  75. Kanno T, Iijima K, Abe Y, et al. Peptic ulcers after the Great East Japan earthquake and tsunami: possible existence of psychosocial stress ulcers in humans. J Gastroenterol 2013;48:483-490. https://doi.org/10.1007/s00535-012-0681-1
  76. Levenstein S, Rosenstock S, Jacobsen RK, Jorgensen T. Psychological stress increases risk for peptic ulcer, regardless of Helicobacter pylori infection or use of nonsteroidal anti-inflammatory drugs. Clin Gastroenterol Hepatol 2015;13:498.e1-506.e1.
  77. Freston JW. Review article: role of proton pump inhibitors in non-H. pylori-related ulcers. Aliment Pharmacol Ther 2001;15 Suppl 2:2-5.
  78. Freston JW. Helicobacter pylori-negative peptic ulcers: frequency and implications for management. J Gastroenterol 2000;35 Suppl 12:29-32.
  79. Howden CW, Leontiadis GI. Current indications for acid suppressants in Helicobacter pylori-negative ulcer disease. Best Pract Res Clin Gastroenterol 2001;15:401-412.
  80. McColl KE. Helicobacter pylori-negative ulcer disease. J Gastroenterol 2000;35 Suppl 12:47-50. https://doi.org/10.1007/PL00009975
  81. Bytzer P, Teglbjaerg PS; Danish Ulcer Study Group. Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis: results from a randomized trial with 2-year follow-up. Am J Gastroenterol 2001;96:1409-1416.
  82. Hyvarinen H, Salmenkyla S, Sipponen P. Helicobacter pylori-negative duodenal and pyloric ulcer: role of NSAIDs. Digestion 1996;57:305-309. https://doi.org/10.1159/000201350
  83. McColl KE, el-Nujumi AM, Chittajallu RS, et al. A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration. Gut 1993;34:762-768. https://doi.org/10.1136/gut.34.6.762
  84. Wong GL, Wong VW, Chan Y, et al. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology 2009;137:525-531. https://doi.org/10.1053/j.gastro.2009.05.006
  85. Gillen D, Wirz AA, Neithercut WD, Ardill JE, McColl KE. Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole. Gut 1999;44:468-475. https://doi.org/10.1136/gut.44.4.468

Cited by

  1. Diagnosis and Treatment of Peptic Ulcer Disease: Present and Future Perspective vol.67, pp.6, 2016, https://doi.org/10.4166/kjg.2016.67.6.318
  2. Helicobacter pylori and non‐malignant upper gastrointestinal diseases vol.21, pp.suppl1, 2015, https://doi.org/10.1111/hel.12337
  3. Seasonal Variations and Trends in Hospitalization for Peptic Ulcer Disease in the United States: A 12-Year Analysis of the Nationwide Inpatient Sample vol.8, pp.10, 2015, https://doi.org/10.7759/cureus.854
  4. Perceived stress as a risk factor for peptic ulcers: a register-based cohort study vol.16, pp.None, 2016, https://doi.org/10.1186/s12876-016-0554-9
  5. Ulcus duodeni, Ulcus ventriculi und Helicobacter pylori vol.50, pp.2, 2015, https://doi.org/10.1007/s00391-017-1190-x
  6. Gastric Cancer and Gastrointestinal Stromal Tumors Could be Causes of non- Helicobacter Pylori non-NSAIDs Peptic Ulcers in Thailand vol.18, pp.1, 2015, https://doi.org/10.22034/apjcp.2017.18.1.155
  7. Refractory gastric antral ulcers without Helicobacter pylori infection and non-steroidal anti-inflammatory drugs vol.11, pp.3, 2018, https://doi.org/10.1007/s12328-018-0835-7
  8. Psychogenic stress in hospitalized veterinary patients: Causation, implications, and therapies vol.29, pp.2, 2015, https://doi.org/10.1111/vec.12821
  9. Is the new potent acid-inhibitory drug vonoprazan effective for healing idiopathic peptic ulcers? A multicenter observational study in Akita Prefecture, Japan vol.54, pp.11, 2019, https://doi.org/10.1007/s00535-019-01587-5
  10. Changes of gastric ulcer bleeding in the metropolitan area of Japan vol.25, pp.42, 2015, https://doi.org/10.3748/wjg.v25.i42.6342
  11. Clinical and genetic feature sof duodenal ulcer vol.9, pp.None, 2015, https://doi.org/10.31146/1682-8658-ecg-169-9-45-49
  12. Clinical and Pathogenetic Aspects of the Course of Peptic Ulcer Disease with Concomitant Duodenal Stasis vol.10, pp.3, 2015, https://doi.org/10.20514/2226-6704-2020-10-3-209-216
  13. Role of the antioxidant properties in the gastroprotective and gastric healing activity promoted by Brazilian green propolis and the healing efficacy of Artepillin C vol.28, pp.4, 2015, https://doi.org/10.1007/s10787-019-00649-7
  14. Seasonal variation of peptic ulcer disease, peptic ulcer bleeding, and acute pancreatitis : A nationwide population-based study using a common data model vol.100, pp.21, 2021, https://doi.org/10.1097/md.0000000000025820
  15. New Trends and Advances in Non-Variceal Gastrointestinal Bleeding-Series II vol.10, pp.14, 2015, https://doi.org/10.3390/jcm10143045
  16. Multi- Factor etiopathogenesis of gastric and duodenal peptic ulcer disease vol.8, pp.None, 2021, https://doi.org/10.31146/1682-8658-ecg-192-8-154-159